Navigation Links
Giant Healthcare Provider to Set Up Massive Gene Bank

led a database containing the genetic makeup and medical history of more than 100,000 citizens of Iceland.

Kaiser's goal of enrolling up to 500,000 of its members is rivaled in ambition only by the government-backed UK Biobank, which was launched last year and also intends to survey and collect genetic material from a similar number of British residents.

Says former U.S. Food and Drug Administration chief Dr. David Kessler, now dean of the University of California-San Francisco medical school: What this will do is make personalized medicine a reality. It is a vitally important effort to improve the health of people everywhere.
ANN
'"/>




Page: 1 2

Related medicine news :

1. Gaming Giants Want A Slice Of Brain Training Pie
2. Giant Tumour Removed from Body of Nepalese Girl
3. Cola Giants Move To Court Over Their Ban In Kerala
4. Turkey Giant to Receive King-sized Compensation
5. Schoolgirls Spark Court Cases Against Drug Giant
6. Healthcare sector is now a multi billion-dollar industry in India
7. Iodex goes to SmithKline Beecham consumer Healthcare
8. Healthcare Professionals Might Want To Rethink Their Dress Code
9. New X-ray machine launched by GE Healthcare
10. Medical Fraternity Urged To Revamp Indian Healthcare
11. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
Post Your Comments:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...DS has been haunting man for many years. There is ...as the disease is fatal and result in death. But n...led//, as they have been successful in determining...ase. HIV is a deadly RNA virus that renders man...
... States has asked the US Food and Drug Administrat...reatment of Attention Deficit Hyperactivity Disord.../ causes cardiovascular diseases such as strokes ... starting of february to review the safety of ADHD...
...study published in today's issue of the journal Na...d by Jane Visvader, of the Walter and Eliza Hall I...ated a stem cell from the breast pads in female mi...ast cancer treatments and reconstructive surgery. ...
...ters of the Communist Party of India-Marxist (CPI-...uary 2006. The supporters of the guru are // rep...Brinda Karat, who leveled charges that the medicin...ody parts. The police have detained 30 of Ramdev’s...
Other Medicine News:
(Date:10/8/2008)...Review Zanolimumab Program to be Discontinued and ... the Results of its Portfolio Review; Zanolimumab ...educe the Number of ...tCall/ -- Genmab A/S (OMX: GEN),announced today th...(HuMax-CD4(R)). In addition, as a result of a port...
(Date:10/8/2008)... -- Exploratory study shows clinical improvement...sion (PAH), -- Current treatment options have l... progressive and incurable blood vessel disease, ...r treatment of certain cancers, known to inhi... further explore potential of imatinib mesylate in...
(Date:10/7/2008)... Results of FLEXX Trial Presented at the Osteoar...d Congress, PARSIPPANY, N.J., Oct. 7 /PRNewswire/...d results from the FLEXX Trial of Osteoarthritis o...aluronate), a highly pure,non-avian high molecular...A-HA), is superior to intra-articular saline (IA-s...
(Date:10/7/2008)... FORT COLLINS, Colo., Oct. 7 /- A s...amining embryonic stem cell self-renewal,reported...stim (recombinant,human serum albumin) was an effe...ll culture., The article entitled, "The ground st...d that researchers used Cellastim as a recombinant...
Breaking Medicine Technology:Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4RAND study finds increase in piracy and terrorism at sea 3536 1RAND study finds increase in piracy and terrorism at sea 3536 2RAND study finds increase in piracy and terrorism at sea 3536 3Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital Acquired Infections 2329 1Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital Acquired Infections 2329 2Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital Acquired Infections 2329 3Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital Acquired Infections 2329 4Indevus Pharmaceuticals Provides Update on NEBIDO 28R 29 NDA Status 21106 1Indevus Pharmaceuticals Provides Update on NEBIDO 28R 29 NDA Status 21106 2Indevus Pharmaceuticals Provides Update on NEBIDO 28R 29 NDA Status 21106 3Indevus Pharmaceuticals Provides Update on NEBIDO 28R 29 NDA Status 21106 4Indevus Pharmaceuticals Provides Update on NEBIDO 28R 29 NDA Status 21106 5SC Magazine 3A Entrust Entelligence Messaging Server Earns Five Stars and Recommended Rating 3533 1SC Magazine 3A Entrust Entelligence Messaging Server Earns Five Stars and Recommended Rating 3533 2SC Magazine 3A Entrust Entelligence Messaging Server Earns Five Stars and Recommended Rating 3533 3
...CO, Calif., April 03, 2007,/PRNewswire-FirstCall/ ...ed results from its second multi-center Phase 2 tr...h evaluated escalating doses,of the immunotherapy ...prostate cancer (HRPC). Additional follow-up of,th...able to that,being employed in the company,s ongoi...
...(BUSINESS WIRE)--Apr 3, 2007 - Arrowhead Research,...on by its,majority-owned subsidiary Calando Pharma...proliferative effect of the siRNA sequence,selecte...ncer,compound, CALAA-01., The paper, entitled "Pot...ubunit RRM2 Reduce Cell Proliferation In vitro and...
Other Medicine Technology:Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 3Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 2Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 3
Heavy. 7.5 mm curved tip.
Delicate Desmarres lid retractors, round serrated handle, very thin blades, polished finish, size 1.
Size 4 - 2.25 mm
The Catalyst system introduces a new level of computer enhanced precision to microsurgical instrumentation. It has an easy to use digital design with advanced microcomputer control of modules and is
Medicine Products: